151 related articles for article (PubMed ID: 29433402)
21. Non-visualized pregnancy losses are prognostically important for unexplained recurrent miscarriage.
Kolte AM; van Oppenraaij RH; Quenby S; Farquharson RG; Stephenson M; Goddijn M; Christiansen OB;
Hum Reprod; 2014 May; 29(5):931-7. PubMed ID: 24603132
[TBL] [Abstract][Full Text] [Related]
22. Human menopausal gonadotropin versus highly purified-hMG in controlled ovarian hyperstimulation for in-vitro fertilisation: does purity improve outcome?
Orvieto R; Meltcer S; Liberty G; Rabinson J; Anteby EY; Nahum R
Gynecol Endocrinol; 2010 Oct; 26(10):733-5. PubMed ID: 20500109
[TBL] [Abstract][Full Text] [Related]
23. Index pregnancy versus post-index pregnancy in patients with recurrent pregnancy loss.
Greenberg T; Tzivian L; Harlev A; Serjienko R; Mazor M; Bashiri A
J Matern Fetal Neonatal Med; 2015 Jan; 28(1):63-7. PubMed ID: 24592815
[TBL] [Abstract][Full Text] [Related]
24. Ovulation induction and controlled ovarian stimulation using letrozole gonadotropin combination: A single center retrospective cohort study.
Arya S; Kupesic-Plavsic S; Mulla ZD; Dwivedi AK; Crisp Z; Jose J; Noble LS
Eur J Obstet Gynecol Reprod Biol; 2017 Nov; 218():123-128. PubMed ID: 28985546
[TBL] [Abstract][Full Text] [Related]
25. Ovulation induction with pulsatile administration of human menopausal gonadotropin.
Koloszár S; Bártfai G; Godó G; Sas M
Acta Chir Hung; 1989; 30(3):237-42. PubMed ID: 2512754
[TBL] [Abstract][Full Text] [Related]
26. A mild ovarian stimulation strategy in women with poor ovarian reserve undergoing IVF: a multicenter randomized non-inferiority trial.
Youssef MA; van Wely M; Al-Inany H; Madani T; Jahangiri N; Khodabakhshi S; Alhalabi M; Akhondi M; Ansaripour S; Tokhmechy R; Zarandi L; Rizk A; El-Mohamedy M; Shaeer E; Khattab M; Mochtar MH; van der Veen F
Hum Reprod; 2017 Jan; 32(1):112-118. PubMed ID: 27836979
[TBL] [Abstract][Full Text] [Related]
27. Frozen-thawed embryo transfer in a natural or mildly hormonally stimulated cycle in women with regular ovulatory cycles: a RCT.
Peeraer K; Couck I; Debrock S; De Neubourg D; De Loecker P; Tomassetti C; Laenen A; Welkenhuysen M; Meeuwis L; Pelckmans S; Meuleman C; D'Hooghe T
Hum Reprod; 2015 Nov; 30(11):2552-62. PubMed ID: 26364081
[TBL] [Abstract][Full Text] [Related]
28. Ovulation induction with human menopausal gonadotropin compared to human urinary follicle-stimulating hormone results in a significant shift in follicular fluid androgen levels without discernible differences in granulosa-luteal cell function.
Polan ML; Daniele A; Russell JB; DeCherney AH
J Clin Endocrinol Metab; 1986 Dec; 63(6):1284-91. PubMed ID: 3097055
[TBL] [Abstract][Full Text] [Related]
29. Recurrent pregnancy losses and gestational age are closely related: an observational cohort study on 759 pregnancy losses.
Coccia ME; Rizzello F; Capezzuoli T; Spitaleri M; Riviello C
Reprod Sci; 2015 May; 22(5):556-62. PubMed ID: 25305129
[TBL] [Abstract][Full Text] [Related]
30. Higher rates of aneuploidy in blastocysts and higher risk of no embryo transfer in recurrent pregnancy loss patients with diminished ovarian reserve undergoing in vitro fertilization.
Shahine LK; Marshall L; Lamb JD; Hickok LR
Fertil Steril; 2016 Oct; 106(5):1124-1128. PubMed ID: 27371114
[TBL] [Abstract][Full Text] [Related]
31. A randomized, single-blind, prospective trial comparing three different gonadotropin doses with or without addition of letrozole during ovulation stimulation in patients with poor ovarian response.
Bastu E; Buyru F; Ozsurmeli M; Demiral I; Dogan M; Yeh J
Eur J Obstet Gynecol Reprod Biol; 2016 Aug; 203():30-4. PubMed ID: 27236602
[TBL] [Abstract][Full Text] [Related]
32. Two vs. three or more primary recurrent pregnancy losses--are there any differences in epidemiologic characteristics and index pregnancy outcome?
Bashiri A; Ratzon R; Amar S; Serjienko R; Mazor M; Shoham-Vardi I
J Perinat Med; 2012 Feb; 40(4):365-71. PubMed ID: 22752766
[TBL] [Abstract][Full Text] [Related]
33. Letrozole combined with low dose highly purified HMG for ovulation induction in clomiphene citrate-resistant infertile Chinese women with polycystic ovary syndrome: a prospective study.
Zhao Y; Ruan X; Mueck AO
Gynecol Endocrinol; 2017 Jun; 33(6):462-466. PubMed ID: 28277124
[TBL] [Abstract][Full Text] [Related]
34. Controlled ovarian stimulation with exclusive FSH followed by stimulation with hCG alone, FSH alone or hMG.
Gomes MK; Vieira CS; Moura MD; Manetta LA; Leite SP; Reis RM; Ferriani RA
Eur J Obstet Gynecol Reprod Biol; 2007 Jan; 130(1):99-106. PubMed ID: 16835006
[TBL] [Abstract][Full Text] [Related]
35. Could the addition of hp-hMG and GnRH antagonists modulate the response in IVF-ICSI cycles?
Requena A; Landeras JL; Martínez-Navarro L; Calatayud C; Sánchez F; Maldonado V; Muñoz M; Fernández M; González A; López S; López R; Pacheco A; Calderón G; Martínez V
Hum Fertil (Camb); 2010 Mar; 13(1):41-9. PubMed ID: 20384441
[TBL] [Abstract][Full Text] [Related]
36. Recurrent pregnancy loss and diminished ovarian reserve.
Hofmann GE; Khoury J; Thie J
Fertil Steril; 2000 Dec; 74(6):1192-5. PubMed ID: 11119749
[TBL] [Abstract][Full Text] [Related]
37. Superovulation and intrauterine insemination vs. superovulation alone in the treatment of unexplained infertility. A randomized study.
Arcaini L; Bianchi S; Baglioni A; Marchini M; Tozzi L; Fedele L
J Reprod Med; 1996 Aug; 41(8):614-8. PubMed ID: 8866392
[TBL] [Abstract][Full Text] [Related]
38. A randomized assessor-blind trial comparing highly purified hMG and recombinant FSH in a GnRH antagonist cycle with compulsory single-blastocyst transfer.
Devroey P; Pellicer A; Nyboe Andersen A; Arce JC;
Fertil Steril; 2012 Mar; 97(3):561-71. PubMed ID: 22244781
[TBL] [Abstract][Full Text] [Related]
39. A comparison of clomiphene/menotropins and D-Trp6-LH-RH/menotropins cycles of IVF-ET in the same patients.
Ron-El R; Caspi E; Golan A; Nachum H; Herman A; Soffer Y; Weinraub Z
Int J Fertil; 1991; 36(3):157-61. PubMed ID: 1678370
[TBL] [Abstract][Full Text] [Related]
40. Duphaston and human menopausal gonadotropin protocol in normally ovulatory women undergoing controlled ovarian hyperstimulation during in vitro fertilization/intracytoplasmic sperm injection treatments in combination with embryo cryopreservation.
Zhu X; Ye H; Fu Y
Fertil Steril; 2017 Sep; 108(3):505-512.e2. PubMed ID: 28697910
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
